CAM
LMAT icon

Capstone Asset Management’s LeMaitre Vascular LMAT Stock Holding History

Capstone Asset Management’s Portfolio LMAT Stock Details LMAT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		$243K Buy
+7,780
New +$225K 0.01% 1401

Other funds holding LMAT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AIC
AWM Investment Company New York $903M AUM 163.47% 1-Year Est. Return
CCA
Conestoga Capital Advisors Wayne, Pennsylvania $5.01B AUM 6.26% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
TAM
THB Asset Management Norwalk, Connecticut $440M AUM 59.59% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Allianz Asset Management
Allianz Asset Management Munich, Germany $95.4B AUM 38.74% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Capstone Asset Management's LMAT Position: Q2 2017 in Review

Capstone Asset Management opened a new position in LeMaitre Vascular (LMAT) in Q2 2017: 7,780 shares worth $243K. The stake represents 0.01% of the portfolio and ranks #1401 among its holdings.

143 funds tracked by Wall St. Rank hold LMAT as of Q2 2017.

  • Capstone Asset Management held 7,780 shares of LeMaitre Vascular worth $243K as of Q2 2017.
  • LeMaitre Vascular was a new Capstone Asset Management position in Q2 2017.
  • LeMaitre Vascular made up 0.01% of Capstone Asset Management's portfolio in Q2 2017, its #1401 holding.
  • 143 funds tracked by Wall St. Rank held LeMaitre Vascular as of Q2 2017.

Based on Capstone Asset Management's 13F filing for Q2 2017, filed 10 Jul 2017.